US judge refuses to block Medicare from negotiating drug prices
By Brendan Pierson (Reuters) -The U.S. government's Medicare health insurance…
N2:DRUGEN
J&J upbeat on 2023 as devices rebound post-COVID, shares jump
By Bhanvi Satija and Patrick Wingrove (Reuters) -Johnson & Johnson on Thursday…